Clinical Trials Browser

Carcinoma, Hepatocellular, Neoplasm Metastasis

Biliary Tract Neoplasms, Cholangiocarcinoma

Locally Advanced Gastric or Gastroesophageal Junction Cancer

Colorectal Neoplasms

Colorectal Cancer Screening

Stomach Neoplasms

Gastric / Gastroesophageal Junction Adenocarcinoma

HER2 IHC3+ Advanced Colorectal Cancer

Carcinoma, Hepatocellular

Esophageal Squamous Cell Carcinoma

Carcinoma, Hepatocellular

Resectable Colon Cancer

Pancreatic cancer, adult

Colonic Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Esophageal Neoplasms

Pancreatic Neoplasms

HER2-positive Colorectal Cancer

Colonic Neoplasms

Carcinoma, Hepatocellular

Esophageal Squamous Cell Carcinoma

Colorectal Neoplasms

Cachexia, Carcinoma, Hepatocellular

Colorectal Neoplasms

PDAC - Pancreatic Ductal Adenocarcinoma

Stomach Neoplasms

Esophageal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Stomach Neoplasms

Esophageal Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Locally Advanced Low Rectal Adenocarcinoma

Appendiceal Neoplasms, Colorectal Neoplasms

Esophageal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting

Esophageal Neoplasms

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Pancreatic Cancer Resectable

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

Pancreatic Neoplasms

Colorectal Neoplasms

Colonic Neoplasms

Rectal Neoplasms

Clinical Trials

Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

SUIVICOLO

A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment

MRD-ATLAS-III

A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs

A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

DIAMOND

RECTIL

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer

The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy

A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer

JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan

A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

SBRT Versus Surgical Resection for Small HCC

TD-NEOE3V3

Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

CIRCULATEIII

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)

Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer

Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

SOP-XH-IRB

The Value of Indocyanine Green-guided Near-infrared Fluorescence Technology in Tracing Sentinel Lymph Nodes During Esophagectomy

Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma

PACHA-02

PTCA199-16

PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

MRD2START

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

FOXHIPECT4

Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study

HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer

Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial

REACT

EC-CRT-008

LEFT-PANC

A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy

A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study